Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 200 of 5804
-
Sister's ovary tissue may restore fertility in early menopause
Disease control Not yet recruitingPremature ovarian failure, also known as primary ovarian insufficiency (POI), or premature menopause, affects 1-2% of women under 40. The diagnosis is typically made based on high levels of follicle stimulating hormone (FSH) and absent or irregular menstrual periods. It leads to …
Phase: NA • Sponsor: University Hospitals Cleveland Medical Center • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Could a new drug beat the current standard for septic shock?
Disease control Not yet recruitingDespite best therapy efforts, sepsis and septic shock are associated with mortality rates of up to 40%. This clinical trial will determine the benefit of exogenous Angiotensin II versus norepinephrine (conventional care) treatment in septic shock patients. This trial will determi…
Phase: PHASE4 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New hope for HIV patients: cheaper chemo may work just as well for kaposi sarcoma
Disease control Not yet recruitingThis study is being done to determine if two different anti-cancer drugs, paclitaxel (PTX) and pegylated liposomal doxorubicin (PLD) have similar effects on treating Kaposi Sarcoma (KS) in people living with HIV (human immunodeficiency virus) in sub-Saharan Africa. Patients with …
Phase: PHASE3 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Simple supplement may slow vision loss in rare eye disease
Disease control Not yet recruitingThe goal of this clinical trial is to look at the efficacy and safety of giving oral serine (an amino acid) on the progression of structural and functional changes of the retina in people with MacTel type 2. The main questions it aims to answer are: * Does serine slow the progre…
Phase: PHASE3 • Sponsor: The Lowy Medical Research Institute Limited • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Could a common diabetes pill ease long COVID?
Disease control Not yet recruitingThis is a randomized, placebo-controlled study. Patients with long COVID will be randomized to receive dapagliflozin or placebo for 12 months.
Phase: PHASE3 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Colombia launches first CAR-T trial for Hard-to-Treat blood cancers
Disease control Not yet recruitingThis is a hybrid type two study, with two simultaneous development phases. Phase A involves developing a public-private partnership to create the conditions for implementing CAR-T cell therapies in Colombia. Phase B will be a single-arm, non-randomized pilot clinical trial in pat…
Phase: NA • Sponsor: GUSTAVO SALGUERO • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Could your own stem cells fight this rare brain disorder?
Disease control Not yet recruitingThis study investigates the safety and efficacy of autologous stem cell therapy in patients with Multiple System Atrophy (MSA), a rare and progressive neurodegenerative disorder characterized by autonomic failure, parkinsonism, and cerebellar ataxia. The trial will evaluate funct…
Phase: PHASE2 • Sponsor: Biocells Medical • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Could a single shot boost stroke recovery? new trial aims to find out
Disease control Not yet recruitingThis study is a prospective, multicenter, double-blind, randomized, placebo-controlled clinical trial designed to evaluate whether early administration of PCSK9 inhibitors can effectively improve functional outcomes at 90 days in patients with ischemic stroke (AIS) associated wit…
Phase: PHASE4 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New MRI dye could spot brain tumors sooner in cancer patients
Diagnosis Not yet recruitingThe survival of patients with CNS metastases often remains limited to some months. CNS metastases are also associated with neurological decline and decrease of quality of life. An early identification of CNS metastases may potentially lead to more therapeutic options and prevent …
Phase: PHASE2 • Sponsor: University of Zurich • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
New pill could help kids with thalassemia fight anemia without transfusions
Disease control Not yet recruitingThe primary objective of this study is to compare the effect of mitapivat versus placebo on anemia in pediatric participants with alpha- or beta-non-transfusion-dependent thalassemia.
Phase: PHASE3 • Sponsor: Agios Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New pill combo aims to control CLL without lifelong treatment
Disease control Not yet recruitingThis is an open-label, single-arm, phase II study which will assess the safety and efficacy of BGB16673 in combination with sonrotoclax as a time-limited approach for participants with treatment-naive CLL/SLL.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New surgical order may boost pancreatic cancer outcomes
Disease control Not yet recruiting"Pancreatic cancer, especially pancreatic ductal adenocarcinoma, is one of the most serious and deadly cancers. Its outlook is very poor, with fewer than 10% of patients surviving five years after diagnosis. This is largely because the disease is often discovered at a late stage …
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New combo therapy targets hard-to-treat lung cancer mutation
Disease control Not yet recruitingThis phase II trial tests how well giving CIMAvax-EGF with KRAS G12C inhibitor (sotorasib or adagrasib) for the treatment of patients with KRAS G12C mutated non small cell lung cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts…
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Can calming the nervous system save lives in septic shock?
Disease control Not yet recruitingSeptic shock is one of the most frequent reasons for admission to intensive care units and remains associated with a high mortality rate of approximatively 40% at 28 days. Nearly half of deaths attributable to septic shock occur within the first 3 days and are directly related to…
Phase: PHASE3 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Tailored breathing support may reduce lung injury in ECMO patients
Disease control Not yet recruitingWhile mechanical ventilation can be used to sustain life in those with lung injury, it, can further worsen lung injury or prevent lung healing resulting in high morbidity and mortality as seen in Acute Respiratory Distress Syndrome (ARDS). Using extracorporeal membrane oxygenati…
Phase: NA • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Smartwatches may help heart patients avoid hospital readmission
Disease control Not yet recruitingWith the advancement of wearable technology, continuous non-invasive monitoring of vital signs, arrhythmia burden, and physical status has become increasingly feasible. Devices such as smartwatches and electrocardiogram (ECG) straps can provide real-time physiological data, offer…
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Sleep drug may shield elderly brains from Post-Surgery confusion
Disease control Not yet recruitingThis prospective, randomized controlled trial aims to investigate the perioperative use of lemborexant, an orexin receptor antagonist, for reducing postoperative delirium (POD) in elderly patients undergoing general anesthesia.
Phase: PHASE2 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Genetic blood test could spare many pregnancies from unnecessary monitoring
Diagnosis Not yet recruitingDetermination of Fetal Blood Group by Next-Generation Sequencing - A Clinical Study in Pregnancies with Maternal Alloantibodies Directed Against Fetal Blood Cells (Alloimmunization During Pregnancy) Maternal antibodies can cross the placenta and reach the fetus during pregnancy.…
Phase: NA • Sponsor: Karolinska University Hospital • Aim: Diagnosis
Last updated Jul 22, 2026 00:00 UTC
-
New pill targets Hard-to-Treat cancers with KRAS mutation
Disease control Not yet recruitingThis is a first-in-human (FIH), multicenter, open-label, phase I study of ABSK211 in participants with advanced solid tumors to evaluate safety, tolerability, PK and optimize the dosage.
Phase: PHASE1 • Sponsor: Abbisko Therapeutics Co, Ltd • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Which IV iron works best for anemia in pregnancy? a Head-to-Head trial
Disease control Not yet recruitingThe goal of this clinical trial is to compare two types of intravenous (IV) iron-Ferric Carboxymaltose (FCM) and Iron Sucrose (IS)-to learn which one works better to treat iron deficiency anemia in pregnant women who have a clear medical need for IV iron. It will also learn about…
Phase: NA • Sponsor: Hawler Medical University • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC